SMP2 and NLMT programme updates
News
Both the CRUK Stratified Medicine Programme (SMP2) and the National Lung Matrix Trial (NLMT) are at a crucial phase of trial delivery. SMP2 and NLMT are open to recruitment at 17 and 16 ECMCs respectively. Both study teams are collaborating to set up three new sites (Liverpool, Maidstone and Devon...
The translational science sub group of QATS (Quality Assurance and Translational Science Group) held its first one-day meeting on 20 March
News
The ECMC Translational Science subgroup of QATS (Quality Assurance & Translational Science group) organised its very first conference titled ‘Opportunities and challenges with emerging biomarker technologies and their application in early phase trials’ on 20 March. The one-day event was held at the ICR in Sutton and organised by Karen Swales, Senior Scientific Officer, ICR CRUK Therapeutics Unit and chair of the Translational Science subgroup.
Cardiff ECMC has begun setting up an ECMC Haematology network, encompassing all haematologic malignancies
News
As part of the new quinquennium, Cardiff ECMC has begun setting up an ECMC Haematology network. The main purpose of this group is to promote haematology activities within the ECMC and consider ways it can work collectively as a group.
Researcher Toolkit for Patient & Public Involvement (PPI) launched 19 June
News
The Public and Patient Involvement team at Cancer Research UK has developed a new Patient and Public Involvement (PPI) in Research Toolkit for the research community. This toolkit is packed with resources, information, and guidance to support PPI in cancer research.
First Paediatric Network Meeting
News
With CRUK and CSO joining NIHR as funders, the ECMC Programme Office will for the first time provide full support for the Paediatric Network through the recent recruitment of a dedicated Paediatric Network Manager. July saw the first Programme Office supported meeting of the ECMC Paediatric Network, bringing together both...
Newcastle University is looking for a new Clinical Chair in Molecular Pathology
News
Newcastle University is seeking to recruit a new Clinical Chair in Molecular Pathology. This exciting opportunity will be advertised in September 2017. We will be looking for a talented and highly motivated individual to spearhead our programme in Molecular Pathology, working closely with the Newcastle EPSRC/MRC Molecular Pathology Node one of six awarded across the UK.
CDD/ECMC Newcastle Workshop summary, 22 June 2017
News
Following on from the success of the first workshop in London earlier this year, CRUK’s Centre for Drug Development (CDD), in collaboration with the ECMC Programme Office, hosted a second workshop, ‘Delivery of Early Phase Trials: How can we excel?’, in Newcastle on 22 June 2017. The workshops formed part...
CDD Biomarker Centres of Excellence announced
News
Cancer Research UK's Centre for Drug Development is pleased to announce the successful conclusion of its tender for biomarker delivery for early phase clinical trial work.
The Programme Office has been busy recruiting!
News
The ECMC Programme Office has successfully recruited to four new roles: Student Combinations Alliance Assistant, Project Officer, Project Manager (Workforce) and Project Manager (Network Capabilities).
Study recommends targeted radiotherapy for early-stage, low-risk breast cancer
News
Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment than those who have whole breast radiotherapy, and their cancer is just as unlikely to return, according to trial results published in The Lancet recently. The Cancer Research UK-funded IMPORT LOW trial revealed that five years after treatment, almost all patients were disease free.